Interleukin 10 inhibits insulin release from and nitric oxide production in rat pancreatic islets

European Journal of Endocrinology

Volumn 135, Issue 3, 1996, Pages 374-378

  Laffranchi, Renato ^a   Spinas, Giatgen A ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; NITRIC OXIDE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FEMALE; MALE; NEWBORN; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; RAT;

EID: 0029861893     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1350374     Document Type: Article

References (30)

1. Corbett JA, Sweetland MA, Wang JL, Lancaster Jr JR, McDaniel ML. Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. Proc Natl Acad Sci USA 1993;90:1731-5
2. Mandrup Poulsen T, Zumsteg U, Reimers J, Pociot F, Morch L, et al. Involvement of interleukin 1 and interleukin 1 antagonist in pancreatic beta-cell destruction in insulin-dependent diabetes mellitus. Cytokine 1993;5:185-91
3. Spinas GA, Palmer JP, Mandrup Poulsen T, Andersen H, Nielsen JH, Nerup J. The bimodal effect of interleukin 1 on rat pancreatic beta cells - stimulation followed by inhibition - depends upon dose, duration of exposure and ambient glucose concentration. Acta Endocrinol (Copenh) 1988;119:307-11
4. Palmer JP, Helqvist S, Spinas GA, Molvig J, Mandrup Poulsen T, Andersen HU, et al. Interaction of beta-cell activity and IL-1 concentration and exposure time in isolated rat islets of Langerhans. Diabetes 1989;38:1211-6
5. Corbett JA, Wang JL, Sweetland MA, Lancaster Jr JR, McDaniel ML. Interleukin 1 beta induces the formation of nitric oxide by beta-cells purified from rodent islets of Langerhans. Evidence for the beta-cell as a source and site of action of nitric oxide. J Clin Invest 1992;90:2384-91
6. Welsh N, Eizirik DL, Bendtzen K, Sandler S. Interleukin-1 beta-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase. Endocrinology 1991;129:3167-73
7. Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991;146: 3444-51
8. Howard M, O'Garra A. Biological properties of interleukin 10. Immunol Today 1992;13:198-200
9. Ishida H, Hastings R, Kearney J, Howard M. Continuous anti-interleukin 10 antibody administration depletes mice of Ly-1 B cells but not conventional B cells. J Exp Med 1992;175:1213-20
10. Gerard C, Bruyns C, Marchant A, Abramowicz D, Vandenabeele P, Delvaux A, et al. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 1993;177:547-50
11. Howard M, Muchamuel T, Andrade S, Menon S. Interleukin 10 protects mice from lethal endotoxemia. J Exp Med 1993;177: 1205-8
12. Gazzinelli RT, Oswald IP, James SL, Sher A. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. J Immunol 1992;148:1792-6
13. Romani L, Puccetti P, Mencacci A, Cenci E, Spaccapelo R, Tonnetti L, et al. Neutralization of IL-10 up-regulates nitric oxide production and protects susceptible mice from challenge with Candida albicans. J Immunol 1994;152:3514-21
14. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1985; 65:55-63
15. Sandler S, Welsh N. Interleukin-10 stimulates rat pancreatic islets in vitro, but fails to protect against interleukin-1. Biochem Biophys Res Commun 1993;195:859-65
16. Mandrup Poulsen T, Spinas GA, Prowse SJ, Hansen BS, Jorgensen DW, Bendtzen K, et al. Islet cytotoxicity of interleukin 1. Influence of culture conditions and islet donor characteristics. Diabetes 1987;36:641-7
17. Dinarello CA, Rosenwasser LJ, Wolff SM. Demonstration of a circulating suppressor factor of thymocyte proliferation during endotoxin fever in humans. J Immunol 1981;127:2517-9
18. Miossec P, Cavender D, Ziff M. Production of interleukin 1 by human endothelial cells. J Immunol 1986;136:2486-91
19. Janjic D, Wollheim CB. Islet cell metabolism is reflected by the MTT (tetrazolium) colorimetric assay. Diabetologia 1992;35:482-5
20. Schmidt HH, Warner TD, Ishii K, Sheng H, Murad F. Insulin secretion from pancreatic-β cells caused by L-arginine-derived nitrogen oxides. Science 1992;255:721-3
21. Laychock SG, Modica ME, Cavanaugh CT. L-Arginine stimulates cyclic guanosine 3′, 5′-monophosphate formation in rat islets of Langerhans and RlNm5F insulinoma cells: evidence for L-arginine:nitric oxide synthase. Endocrinology 1991;129:3043-52
22. Laffranchi R, Gogvadze V, Richter C, Spinas GA. Nitric oxide (nitrogen monoxide, NO) stimulates insulin secretion by inducing calcium release from mitochondria. Biochem Biophys Res Commun 1995;217:584-91
23. Jones PM, Persaud SJ, Bjaaland T, Pearson JD, Howell SL. Nitric oxide is not involved in the initiation of insulin secretion from rat islets of Langerhans. Diabetologia 1992;35:1020-7
24. Moritani M, Yoshimoto K, Tashiro F, Hashimoto C, Miyazaki J, Ii S, et al. Transgenic expression of IL-10 in pancreatic islet A cells accelerates autoimmune insulitis and diabetes in non-obese diabetic mice. Int Immunol 1994;6:1927-36
25. Wogensen L, Lee MS, Sarvetnick N. Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice. J Exp Med 1994;179:1379-84
26. Lee MS, Wogensen L, Shizuru J, Oldstone MB, Sarvetnick N. Pancratic islet production of murine interleukin-10 does not inhibit immune-mediated tissue destruction. J Clin Invest 1994; 93:1332-8
27. Pennline KJ, Roque Gaffney E, Monahan M. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin Immunol Immunopathol 1994;71:169-75
28. Jacob CO, Aiso S, Michie SA, McDevitt HO, Acha Orbea H. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1. Proc Natl Acad Sci USA 1990;87:968-72
29. Satoh J, Seino H, Abo T, Tanaka S, Shintani S, Ohta S, et al. Recombinant human tumor necrosis factor alpha suppresses autoimmune diabetes in nonobese diabetic mice. J Clin Invest 1989;84:1345-8
30. Yoshizumi M, Perrella MA, Burnett Jr JC, Lee ME. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res 1993;73:205-9